Retinal and nonocular abnormalities in Cyp27a1(-/-)Cyp46a1(-/-) mice with dysfunctional metabolism of cholesterol

Aicha Saadane1, Natalia Mast1, Casey D Charvet1

  • 1Department of Ophthalmology and Visual Sciences, Cleveland, Ohio.

Insights

Cholesterol metabolism is crucial for retinal health. Disrupting key enzymes (CYP27A1 and CYP46A1) in mice caused severe retinal vascular and cellular damage, highlighting new disease targets.

Area of Science:

  • Biochemistry
  • Ophthalmology
  • Cell Biology

Background:

  • Cholesterol elimination from nonhepatic cells relies on side-chain oxysterols.
  • Cholesterol metabolism is tissue-specific, with limited understanding in the retina.
  • Cytochromes P450, specifically CYP27A1 and CYP46A1, are major retinal cholesterol-metabolizing enzymes.

Purpose of the Study:

  • To investigate the role of retinal cholesterol metabolism in maintaining retinal structure and function.
  • To establish the significance of CYP27A1 and CYP46A1 in the retina.
  • To identify potential therapeutic targets for retinal vascular diseases.

Main Methods:

  • Generation of Cyp27a1(-/-)Cyp46a1(-/-) double knockout mice.
  • Analysis of retinal vasculature, retinal structure, and nonocular organs.
  • Biochemical and histological examination of cholesterol deposition and cellular changes.

Main Results:

  • Cyp27a1(-/-)Cyp46a1(-/-) mice exhibited significant retinal vascular abnormalities, including anastomoses, shunts, and increased permeability.
  • Cholesterol and cholestanol deposition occurred in the retinal pigment epithelium.
  • Activated retinal macrophages and oxidative stress in photoreceptors were observed.

Conclusions:

  • Retinal cholesterol metabolism, mediated by CYP27A1 and CYP46A1, is essential for normal retinal integrity.
  • Disruption of these enzymes leads to profound retinal vascular and cellular pathology.
  • These findings suggest novel therapeutic strategies for retinal vascular diseases.